# Cycle 2 Quality Scorecard - Thread 06

## Preserved History

| Cycle | Creator | ChatGPT reviewer | Critical | High | Decision |
| --- | ---: | ---: | ---: | ---: | --- |
| 1 | 90 | 81 | 0 in research scope | 2 author plus review defects | Revise |
| 2 | 88 | Pending | 0 in research scope | 5 unresolved evidence/external gates | Revise |

## Self-Score

| Dimension | Weight | Awarded | Evidence | Lost points |
| --- | ---: | ---: | --- | --- |
| Requirement coverage | 15 | 15 | Schemas, scope, receipts, lifecycle, ally, outcomes, care, inclusion. | None identified in documentation. |
| Privacy/consent/minimization | 15 | 14 | Minimal default, optional extended fields, receipt invalidation and deletion. | Thread 07 implementation architecture pending. |
| Safety and autonomy | 15 | 14 | Non-clinical boundary, independent recovery, coercion/essential access/stop rules. | Specialist/user evidence absent. |
| Product coherence | 15 | 14 | Constitution connects mode, policy, context, adapter, outcome, and exit. | Cross-thread integration untested. |
| Evidence/method quality | 15 | 10 | Transfer limits, outcomes, adverse effects, interpretation ceilings. | No product outcome evidence or validated instruments. |
| Inclusion/accessibility | 10 | 8 | Explicit review domains and non-inference requirements. | No lived-experience/accessibility/localization testing. |
| Traceability/testability | 10 | 9 | Scenarios, receipt fields, versions, stop signals. | Quantitative criteria pending. |
| Verification | 5 | 4 | Internal taxonomy/schema/scenario/diff review before push. | No implementation or participant test. |
| **Total** | **100** | **88** |  |  |

- Critical defects: 0 in research-only scope; participant/enforcement use remains prohibited.
- High defects: user evidence, naming, specialist approvals, adapter/mode thresholds, and outcome/adverse thresholds absent.
- Medium defects: exact receipt/UX copy and localization not tested.
- Low defects: terminology requires user editing.
- Confidence: Medium for product definition; Low for safety/effectiveness in use.

Decision: **Revise. Keep PR #35 Draft. Do not implement or use with participants.**
